Report
Rob Hales, CFA
EUR 147.86 For Business Accounts Only

Initiating Coverage of Evonik With a No-Moat Rating and EUR 30 Fair Value Estimate

We are initiating coverage of Evonik Industries with a no-moat rating and a fair value estimate of EUR 30 per share, implying a price/earnings ratio of 16 times, based on 2016 estimates. At current levels, shares look fairly valued. Evonik is a German chemical company offering a mix of speciality and commodity chemical products with a number-one to -three market position in 80% of its businesses. Nearly two thirds of its products are targeted at industrial end markets, particularly automotive an...
Underlying
Evonik Industries AG

Steag, through its subsidiaries, is engaged mainly in power generation and related industries. Co.'s business is divided into five units: Power generation, Decentralized Energy Supply, Foreign Power Plants, Gas Distribution, and Coal Trading.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Rob Hales, CFA

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch